ANSWER: Invictus Oncology Pvt Ltd
Explanation:
Ratan Tata, the chairman emeritus of TATA Sons, has made the investment of a non disclosed amount in Delhi’s biopharma firm Invictus Oncology Pvt Ltd which is involved in uncovering cancer therapies. Invictus Oncology is the fifth firm Tata has invested in after Tracxn, DogSpot, FirstCry and CashKaro. This firm uses supramolecular technology platform for designing cancer treatment drugs. This company has also developed a deep pipeline of molecules tapping a USD 20 billion market opportunity in oncology space.